Skip to main content
Scilex Holding Co logo

Scilex Holding Co — Investor Relations & Filings

Ticker · SCLX ISIN · US80880W2052 LEI · 529900SPEA2C7YTTYP45 US Manufacturing
Open in API
Filings indexed 686 across all filing types
Latest filing 2021-01-07 Director's Dealing
Country US United States of America
Listing US SCLX

About Scilex Holding Co

https://www.scilexholding.com/

Scilex Holding Co. is a company focused on the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company's portfolio targets indications with high unmet medical needs and features therapies with proprietary drug delivery systems. These systems include an advanced topical patch technology for optimized drug delivery through the skin, an anti-inflammatory oral solution designed for individualized dosing in high-risk patients, and a liquid ready-to-use analgesic for migraine relief. Scilex aims to provide effective alternatives to opioid medications to improve patient quality of life.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2021-01-07 English
PRIMARY DOCUMENT
Director's Dealing
2021-01-07 English
Regulatory Filings 2021
Regulatory Filings
2021-01-06 English
REGISTRATION OF CERTAIN CLASSES OF SECURITIES
Regulatory Filings Classification · 100% confidence The document is a Form 8-A filed with the U.S. Securities and Exchange Commission for the registration of certain classes of securities pursuant to Section 12(b) or 12(g) of the Securities Exchange Act of 1934. It details the registration of units, ordinary shares, and redeemable warrants of Vickers Vantage Corp. I to be listed on The Nasdaq Stock Market LLC. The document is a registration statement, not a financial report, earnings release, or any other type of report. It is a regulatory filing related to securities registration. Given the nature and content, this fits best under Regulatory Filings (RNS). The document length is under 5,000 characters and it is a formal SEC filing form, confirming it is not a report but a regulatory filing.
2021-01-06 English
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the SEC regarding a Registration Statement on Form S-1, specifically requesting acceleration of the effective date of the registration statement. It references compliance with SEC rules related to securities offerings and distribution of a Preliminary Prospectus. The document is short (1714 characters) and is a correspondence related to a securities registration process, not a financial report or earnings release. It does not contain financial statements or detailed financial data. This type of document is best classified as a Regulatory Filing (RNS), as it is a regulatory communication related to securities registration and compliance, not a report or announcement of financial results or capital changes.
2021-01-05 English
Capital/Financing Update 2021
Capital/Financing Update Classification · 95% confidence The document is a letter from Vickers Vantage Corp. I to the SEC requesting acceleration of effectiveness of a Registration Statement on Form S-1. This is related to capital raising and securities registration, not a financial report or other types of filings. The mention of Form S-1 and Rule 461 indicates it is about capital/financing activities. The document is short and is a formal request, not a report or announcement of voting results or management changes. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2021-01-05 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.